DEFINITIVE NOTICE AND PROXY STATEMENT

Company

FILANA THERAPEUTICS, INC.

Filed

April 26, 2004

Period of Report

May 27, 2004

Accession Number

0001193125-04-069518

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →